StonvexLoading…
StonvexStonvexStonvexCore line items from SYM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Annual 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $716.64M | $1.31B | $629.99M | $2.25B | $1.63B |
Operating Income | Not available | $12.62M | $6.53M | $-115.01M | $-93.24M |
Net Income | Not available | $4.57M | $2.60M | $-16.94M | $-13.31M |
EPS (Diluted) | $0.17 | $0.03 | $0.02 | $-0.16 | $-0.12 |
Total Assets | Not available | $3.50B | $2.99B | $2.40B | $1.83B |
Total Liabilities | Not available | $2.47B | $2.03B | $1.92B | $1.38B |
Cash & Equivalents | Not available | $2.01B | $1.82B | $1.24B | $777.58M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 602.52M | 599.77M | 590.89M | 589.83M |